In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Tissue Science Laboratories PLC

Division of Medtronic PLC

Latest From Tissue Science Laboratories PLC

Covidien - Back on Top: An Interview with Richard Meelia

Is there a medical device company today doing better than Covidien? The company is making a huge splash building new businesses and shoring up existing ones. But Covidien, formerly Tyco, hasn't always had it so good. A corporate scandal in the early 2000s brought Tyco's corporate management down and scuttled the healthcare business' strategic plan. After years of sitting on the sidelines, Covidien is back, stronger than ever.
Strategy Business Strategies

Wound Care: Finding a Niche

The relatively open nature of the wound care market has created a golden opportunity for manufacturers to step up and introduce a variety of new products, although rarely is new a signal of true innovation in this space. And that, in turn, has created a broad, diverse, and fragmented industry, as demonstrated by the packed exhibit hall at the April 2010 meeting of the Symposium on Advanced Wound Care and the Wound Healing Society.
Medical Device

Spun Out, Covidien Rolls On

Covidien, nearly a year removed from spinning out of scandal-plagued parent Tyco International, is pushing forward as an independent company. Covidien execs are investing in new product creation, sales and marketing efforts, and acquisitions. That means Covidien is about to make a big splash in the device industry, with devices bringing in two-thirds of this ambitious company's revenues.
Strategy Business Strategies

Closing the Gap in Ventral Hernia Repair

Most complex ventral, or incisional, hernias are managed by open surgical techniques, and the choice of prosthetic mesh used in these procedures has become a hot issue. With prices upwards of $10,000 per patient for patch materials, it is no surprise that all eyes are on the ventral hernia patch market.
Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
    • Biomaterials
    • Implantable Devices
    • Surgical Equipment & Devices
  • Therapeutic Areas
  • Wound Healing & Tissue Repair
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Medtronic PLC
  • Senior Management
  • Martin Hunt, CEO
    David Jennings, CFO
    Patrick Paul, Chmn.
  • Contact Info
  • Tissue Science Laboratories PLC
    Phone: (44) 252 333 002
    Victoria House
    Victoria Rd.
    Aldershot, GU11 1EJ